Free Trial

Moderna (MRNA) News Today

$151.01
-3.68 (-2.38%)
(As of 06/7/2024 ET)
Public Employees Retirement Association of Colorado Sells 23,511 Shares of Moderna, Inc. (NASDAQ:MRNA)
Public Employees Retirement Association of Colorado lowered its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 32.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 48,967 shares of the company's stock after sellin
3 Reasons to Buy Moderna Stock
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares of Stock
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business's stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $151.25, for a total transaction of $2,268,750.00. Following the transaction, the director now directly owns 1,946,931 shares of the company's stock, valued at $294,473,313.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Pinebridge Investments L.P.
Pinebridge Investments L.P. raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 22.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,993 shares of the company's stock after acquiring an addi
Cibc World Markets Corp Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)
Cibc World Markets Corp boosted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 56.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 97,211 shares of the company's stock after purchasing an additional 35,154 shares during the period. C
Bank of Nova Scotia Has $4.55 Million Position in Moderna, Inc. (NASDAQ:MRNA)
Bank of Nova Scotia boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 68.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,800 shares of the company's stock after buying an additional 18,574
Belpointe Asset Management LLC Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA)
Belpointe Asset Management LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 101.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,265 shares of the company's stock after p
Moderna (NASDAQ:MRNA) Price Target Raised to $160.00
Lingotto Investment Management LLP Has $23.18 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)
Lingotto Investment Management LLP boosted its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 233,095 shares of the company's stock after acquiri
Needham & Company LLC Reiterates "Hold" Rating for Moderna (NASDAQ:MRNA)
Needham & Company LLC restated a "hold" rating on shares of Moderna in a research note on Monday.
Focus Financial Network Inc. ADV Purchases Shares of 5,997 Moderna, Inc. (NASDAQ:MRNA)
Focus Financial Network Inc. ADV acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,997 shares of the company's stock
Alberta Investment Management Corp Acquires 9,900 Shares of Moderna, Inc. (NASDAQ:MRNA)
Alberta Investment Management Corp boosted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 11.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,725 shares o
Moderna, Inc. (NASDAQ:MRNA) President Stephen Hoge Sells 341 Shares
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 341 shares of Moderna stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $144.50, for a total transaction of $49,274.50. Following the completion of the transaction, the president now owns 1,471,777 shares in the company, valued at approximately $212,671,776.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Moderna (NASDAQ:MRNA) Stock Price Down 6.2%
Advisory Services Network LLC Buys 5,667 Shares of Moderna, Inc. (NASDAQ:MRNA)
Advisory Services Network LLC raised its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 80.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,715 shares of the company's stock after buying an additional 5,667 share
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) CFO Sells $105,280.56 in Stock
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) CFO James M. Mock sold 648 shares of the business's stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $162.47, for a total value of $105,280.56. Following the completion of the sale, the chief financial officer now owns 5,726 shares of the company's stock, valued at $930,303.22. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Moderna Shares Had a Bad Day. Here's Why.
Get Moderna News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.

Nvidia’s Quiet $1 Trillion Pivot (Ad)

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.

MRNA Media Mentions By Week

MRNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRNA
News Sentiment

0.65

0.75

Average
Medical
News Sentiment

MRNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRNA Articles
This Week

30

19

MRNA Articles
Average Week

Get Moderna News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MRNA) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners